Molycorp (MCP) Prices Common Offering at $6/Share
Tweet
Share
E-mailGet Alerts MCP Hot Sheet
Join SI Premium – FREE
Molycorp, Inc. (NYSE: MCP) today announced the pricing of its previously announced public offering of 37,500,000 shares of its common stock (the "Common Stock") (or up to an aggregate of 43,125,000 shares of Common Stock if the underwriters of such offering exercise their option to purchase additional shares of Common Stock in full) at a price per share of $6.00 (the "Primary Shares Offering") and $150 million aggregate principal amount (or up to an aggregate of $172.5 million aggregate principal amount if the underwriters of such offering exercise their over-allotment option in full) of its 5.50% Convertible Senior Notes due 2018 (the "Notes") (the "Notes Offering") in separate registered public offerings.
The Company expects to close each of the Notes Offering and the Primary Shares Offering on January 30, 2013, subject to satisfaction of customary closing conditions.
The Notes will be Molycorp`s senior unsecured obligations and will bear interest at a rate of 5.50% per annum, payable semi-annually in arrears on February 1 and August 1 of each year, commencing on August 1, 2013. The Notes will be convertible at any time into shares of Molycorp`s common stock, cash, or a combination thereof, at Molycorp`s election. The conversion rate will initially be 138.8889 shares of Molycorp common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $7.20 per share of Molycorp`s common stock), subject to customary adjustments. The Notes will mature on February 1, 2018, unless earlier repurchased, redeemed or converted in accordance with their terms prior to that date. Molycorp will have the right to redeem the Notes on or after February 1, 2016 if the last reported sale price of its Common Stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period.
The Company intends to use the net proceeds received from the Primary Shares Offering and the Notes Offering to fund current capital needs for capital expenditures and other cash requirements for 2013, including, without limitation, capital expenditures at its Mountain Pass facility.
Concurrently with the Primary Shares Offering and the Notes Offering, the Company has entered into a share lending agreement with Morgan Stanley Capital Services LLC ("MSCS"), an affiliate of Morgan Stanley & Co. LLC ("Morgan Stanley"), under which it has agreed to loan to MSCS up to 7,666,666 shares of Common Stock (the "Borrowed Shares"), of which 6,333,333 shares of Common Stock were offered through Morgan Stanley at a price per share of $6.00 (the "Borrowed Shares Offering") in a registered public offering. The Company is entering into the share lending agreement to facilitate the Notes Offering. The Company will not receive any proceeds from the Borrowed Shares Offering, but the Company will receive a nominal lending fee from MSCS for the use of the Borrowed Shares, which the Company intends to use for general corporate purposes.
The Company expects to close each of the Notes Offering and the Primary Shares Offering on January 30, 2013, subject to satisfaction of customary closing conditions.
The Notes will be Molycorp`s senior unsecured obligations and will bear interest at a rate of 5.50% per annum, payable semi-annually in arrears on February 1 and August 1 of each year, commencing on August 1, 2013. The Notes will be convertible at any time into shares of Molycorp`s common stock, cash, or a combination thereof, at Molycorp`s election. The conversion rate will initially be 138.8889 shares of Molycorp common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $7.20 per share of Molycorp`s common stock), subject to customary adjustments. The Notes will mature on February 1, 2018, unless earlier repurchased, redeemed or converted in accordance with their terms prior to that date. Molycorp will have the right to redeem the Notes on or after February 1, 2016 if the last reported sale price of its Common Stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period.
The Company intends to use the net proceeds received from the Primary Shares Offering and the Notes Offering to fund current capital needs for capital expenditures and other cash requirements for 2013, including, without limitation, capital expenditures at its Mountain Pass facility.
Concurrently with the Primary Shares Offering and the Notes Offering, the Company has entered into a share lending agreement with Morgan Stanley Capital Services LLC ("MSCS"), an affiliate of Morgan Stanley & Co. LLC ("Morgan Stanley"), under which it has agreed to loan to MSCS up to 7,666,666 shares of Common Stock (the "Borrowed Shares"), of which 6,333,333 shares of Common Stock were offered through Morgan Stanley at a price per share of $6.00 (the "Borrowed Shares Offering") in a registered public offering. The Company is entering into the share lending agreement to facilitate the Notes Offering. The Company will not receive any proceeds from the Borrowed Shares Offering, but the Company will receive a nominal lending fee from MSCS for the use of the Borrowed Shares, which the Company intends to use for general corporate purposes.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
- Enliven Therapeutics, Inc (ELVN) Files for 6.43M Share Offering by Selling Stockholders
- Korro Bio (KRRO) Announces $70M Placement
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
